Sacred Knowledge – Psychedelics and Religious Experiences
Sacred Knowledge – Psychedelics and Religious Experiences Read More »
8 December 2015
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study
Abstract
Ayahuasca is an Amazonian botanical hallucinogenic brew which contains dimethyltryptamine, a 5-HT2A receptor agonist, and harmine, a monoamine-oxidase A inhibitor. Our group recently reported that ayahuasca administration was associated with fast-acting antidepressive effects in 6 depressive patients. The objective of the present work was to assess the antidepressive potentials of ayahuasca in a bigger sample and to investigate its effects on regional cerebral blood flow. In an open-label trial conducted in an inpatient psychiatric unit, 17 patients with recurrent depression received an oral dose of ayahuasca (2.2 mL/kg) and were evaluated with the Hamilton Rating Scale for Depression, the Montgomery-Asberg Depression Rating Scale, the Brief Psychiatric Rating Scale, the Young Mania Rating Scale, and the Clinician Administered Dissociative States Scale during acute ayahuasca effects and 1, 7, 14, and 21 days after drug intake. Blood perfusion was assessed eight hours after drug administration by means of single photon emission tomography. Ayahuasca administration was associated with increased psychoactivity (Clinician Administered Dissociative States Scale) and significant score decreases in depression-related scales (Hamilton Rating Scale for Depression, Montgomery-Asberg Depression Rating Scale, Brief Psychiatric Rating Scale) from 80 minutes to day 21. Increased blood perfusion in the left nucleus accumbens, right insula and left subgenual area, brain regions implicated in the regulation of mood and emotions, were observed after ayahuasca intake. Ayahuasca was well tolerated. Vomiting was the only adverse effect recorded, being reported by 47% of the volunteers. Our results suggest that ayahuasca may have fast-acting and sustained antidepressive properties. These results should be replicated in randomized, double-blind, placebo-controlled trials.
Sanches, R. F., de Lima, O. F., Dos Santos, R. G., Macedo, L. R., Maia-de-Oliveira, J. P., Wichert-Ana, L., … & Hallak, J. E. (2015). Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study. Journal of clinical psychopharmacology. http://dx.doi.org/10.1097/JCP.0000000000000436
Sacred Knowledge enriches humanities and scientific scholarship, expanding work in philosophy, anthropology, theology, and religious studies, as well as in mental health, psychotherapy, and psychopharmacology. Richards’s analysis also contributes to social and political debates over the responsible integration of psychedelic substances into modern society. His book is an invaluable resource for readers who, whether spontaneously or with the facilitation of psychedelics, have encountered meaningful, inspiring, or even disturbing states of consciousness and seek clarity about their experiences. Testing the limits of language and conceptual frameworks, Richards makes the most of experiential phenomena that stretch our concepts of reality and advances new frontiers in the study of belief, spiritual awakening, psychiatric treatment, and social well-being.
William A. Richards is a clinical psychologist with formal training in theology and comparative religion at Johns Hopkins Bayview Medical Center. Earlier in his career, he pursued psychedelic research at the Spring Grove Hospital and Maryland Psychiatric Research Center in Baltimore. His graduate education included studies at Yale University, Brandeis University, Catholic University, the Andover-Newton Theological School, and the University of Göttingen.
Sacred Knowledge: Psychedelics and Religious Experiences, by William A. Richards, Columbia University Press, 280 pages.
Read our review of this book
Buy this book at bookdepository.com and support the OPEN Foundation.